Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy.

Inflammatory bowel diseases - 1 Mar 2015

Henderson Paul, Kennedy Nicholas A, Van Limbergen Johan E, Cameron Fiona L, Satsangi Jack, Russell Richard K, Wilson David C

Abstract excerpt

BACKGROUND: C-reactive protein (CRP) is an acute phase reactant. Patients with pediatric inflammatory bowel disease (PIBD) differ from adult patients with inflammatory bowel disease with regard to phenotype, inflammatory profile, and treatment response. We hypothesized that variations in CRP and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Azathioprine
Share to Biomarkers
Share to C-Reactive Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colitis, Ulcerative

Share to Combined Modality Therapy

Share to Crohn Disease

Share to Disease Progression

Share to Tumor Necrosis Factor-alpha

Source

Identifiers

PMID: 25636121
DOI: 10.1097/MIB.0000000000000296

Genes

CRP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25636121-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serum C-reactive protein and CRP genotype in pediatric inflammatory bowel disease: influence on phenotype, natural history, and response to therapy.PMID 25636121Read ↗

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children.Semantic proximity Read ↗

Macrophage-Stimulating 1 Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease.Semantic proximity Read ↗

Baseline Characteristics and Disease Phenotype in Inflammatory Bowel Disease.Semantic proximity Read ↗

How does knowledge from translational research impact our clinical care of pediatric inflammatory bowel disease patients?Semantic proximity Read ↗

Genetic Variation Affects C-Reactive Protein Elevations in Crohn's Disease.Semantic proximity Read ↗

Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn's Disease: Results from the CONNECT Study.Semantic proximity Read ↗

Serologic Reactivity Reflects Clinical Expression of Ulcerative Colitis in Children.Semantic proximity Read ↗

IL10 rs1800896 Genetic Variant Predicts Biochemical Remission in Inflammatory Bowel Disease Patients Undergoing Biologic Therapy.Semantic proximity Read ↗

Cytokine Tumor Necrosis Factor‐alpha A Promoter Gene Polymorphism at Position −308 G→A and Pediatric Inflammatory Bowel DiseaseSemantic proximity Read ↗

Age of diagnosis influences serologic responses in children with Crohn's disease: a possible clue to etiology?Semantic proximity Read ↗

Diagnostic utility and phenotype correlation of serum ASCA and ANCA in pediatric inflammatory bowel diseaseSemantic proximity Read ↗

IL6 genetic variants haplotype is associated with susceptibility and disease activity but not with therapy response in patients with inflammatory bowel disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.